thrombolytic therapy
The increase in AMI risk on the first day of       thrombolytic therapy in this study might be closely related to thrombolysis and       to the lack of strong antithrombin therapy.
The increase in  @OBJECT$   @PREDICAT$  on the first day of        @SUBJECT$  in this study might be closely related to thrombolysis and       to the lack of strong antithrombin therapy.